Table: Mochida Pharm -2025/26 parent results
May 15 (Reuters)-
Mochida Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 106.09 95.41
(+11.2 pct) (+1.2 pct)
Operating 6.41 5.48
(+16.9 pct) (+70.2 pct)
Recurring 8.69 7.57
(+14.7 pct) (+41.4 pct)
Net 6.56 5.38
(+21.8 pct) (+15.2 pct)
EPS 184.94 yen 151.87 yen
Ann Div 80.00 yen 80.00 yen 85.00 yen
-Q2 Div 40.00 yen 40.00 yen 42.50 yen
-Q4 Div 40.00 yen 40.00 yen 42.50 yen
NOTE - Mochida Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T